Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Loxo Oncology Inc (NASDAQ:LOXO)

80.17
Delayed Data
As of Jun 23
 +1.59 / +2.02%
Today’s Change
17.14
Today|||52-Week Range
83.12
+149.63%
Year-to-Date
No recent news for Loxo Oncology Inc.

Today’s Trading

Previous close78.58
Today’s open78.18
Day’s range76.88 - 80.47
Volume900,548
Average volume (3 months)369,629
Market cap$2.3B
Dividend yield--
Data as of 4:14pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)-63.21%
Earnings growth (this year)-16.91%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book13.35

Competitors

 Today’s
change
Today’s
% change
TBPHTheravance Biopharma...-0.18-0.42%
PRTAProthena Corporation...+1.74+3.05%
SUPNSupernus Pharmaceuti...+0.50+1.15%
AXONAxovant Sciences Ltd-0.13-0.54%
Data as of 4:01pm ET, 06/23/2017

Financials

Next reporting dateSeptember 15, 2017
EPS forecast (this quarter)-$0.96
Annual revenue (last year)$0.00
Annual profit (last year)-$72.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Josh Bilenker
Executive Director-
Business Operations
Sara Slifka
Corporate headquarters
Stamford, Connecticut

Forecasts